Clinical Study of AK159 in Healthy Postmenopausal Women

NCT01551602 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: AK159
DRUG: MN-10-T
DRUG: Placebo

Sponsor

Asahi Kasei Therapeutics Corporation